Celltrion USA Announces Submission of BLA for Subcutaneous Infliximab Biosimilar
BPCIA Aflibercept Litigation: Regeneron Files 12(c) Motion to Dismiss Mylan’s Counterclaim for Inequitable Conduct
The UK’s MHRA Updates its Guidance on Licensing of Biosimilars
Celltrion Files IND with FDA for Adalimumab Biosimilar
EMA CHMP Recommends Grant of Marketing Authorization for Three Biosimilars
JSR Life Sciences Launches New “Similis Bio” Business Division to Accelerate Biosimilar Development
FDA Announces Biosimilar Funding Opportunity
China Accepts Innovent Biologics’ Supplemental New Drug Application for Sintilimab Plus Bevacizumab Biosimilar Injection
Alvotech’s E.D. Va. Declaratory Judgment Action Against AbbVie Transferred to N.D. Ill.
Subscribe: Subscribe via RSS
Blogs
Firm/Org